(Applicant's list of Aims) Specific Aim 1. To assess the dynamics of platelet-leukocyte interactions using intravital microscopy in mouse models of thrombosis in the mesenteric and cremasteric circulations.
Specific Aim 2. To assess whether leukocyte deposition on platelets after vascular injury contributes to blood vessel passivation, that is, a return to a state in which platelets are no longer recruited. Deposition of radiolabeled platelets over select 30 min periods for 6 hours after femoral artery injury will be measured in wild-type mice, beta3 integrin -/- mice, P-selectin -/- mice, alphaMbeta -/- mice, and PECAM-1 -/- mice.
Specific Aim 3. To assess the role of platelet-leukocyte interactions in leukocyte transmigration and the development of intimal hyperplasia after vascular injury. Using our murine model, leukocyte transmigration into the blood vessel media during the first 6 hours will be assessed and correlated with the intimal hyperplasia that develops after 4 weeks in wild-type mice and mice deficient in beta3 integrins, P-selectin, alphaMbeta2, and PECAM-1.
Specific Aim 4. To assess ex vivo the effects of platelet-leukocyte interactions during contact of normal whole human blood with a stainless steel stent on: 1) thrombus formation; 2) release into the downstream circulation of tissue factor; thrombin; activated platelets (P- selectin); activated neutrophils (alphaMbeta2); platelet-neutrophil, platelet- monocyte, and platelet-platelet aggregates; platelet microparticles; VEGF; the cytokine 1-309; and """"""""soluble"""""""" CD40 ligand; 3) passivation of platelet deposition on the stent, and 4) stent thrombus morphology. Studies using blocking antibodies to GPIIb/IIIa and/or alphaVbeta3, P-selectin, alphaMbeta2, and PECAM-1 will be conducted to assess the contributions of these receptors.
Specific Aim 5. To assess the presence of platelet- leukocyte interactions in the systemic circulation of patients with risk factors for thrombosis and controls, before and after interventions to modify the risk factors, and correlate these findings with markers of a systemic inflammatory state (see Project 1). Blood will be tested for platelet- neutrophil aggregates, platelet-monocyte aggregates, platelet-platelet aggregates, leukocyte alphaMbeta2 expression, platelet P-selectin expression, and platelet microparticles. These data will be correlated with data obtained on circulating tissue factor, C-reactive protein, tissue factor pathway inhibitory, prothrombin fragment F1.2, and thrombus formation in flow chamber studies.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Specialized Center (P50)
Project #
5P50HL054469-07
Application #
6571856
Study Section
Project Start
2002-03-01
Project End
2003-01-31
Budget Start
Budget End
Support Year
7
Fiscal Year
2002
Total Cost
Indirect Cost
Name
Mount Sinai School of Medicine
Department
Type
DUNS #
City
New York
State
NY
Country
United States
Zip Code
10029
Johnson-Huang, Leanne M; Suárez-Fariñas, Mayte; Sullivan-Whalen, Mary et al. (2010) Effective narrow-band UVB radiation therapy suppresses the IL-23/IL-17 axis in normalized psoriasis plaques. J Invest Dermatol 130:2654-63
Choi, Brian G; Vilahur, Gemma; Zafar, M Urooj et al. (2008) Selective estrogen receptor modulation influences atherosclerotic plaque composition in a rabbit menopause model. Atherosclerosis 201:76-84
Worthley, Stephen G; Helft, Gerard; Corti, Roberto et al. (2007) Statin therapy alone and in combination with an acyl-CoA:cholesterol O-acyltransferase inhibitor on experimental atherosclerosis. Pathophysiol Haemost Thromb 36:9-17
Corti, Roberto; Osende, Julio; Hutter, Randolph et al. (2007) Fenofibrate induces plaque regression in hypercholesterolemic atherosclerotic rabbits: in vivo demonstration by high-resolution MRI. Atherosclerosis 190:106-13
Choi, Brian G; Novoselsky, Constantin A; Vilahur, Gemma et al. (2007) Validation study of a semi-automated program for quantification of atherosclerotic burden. J Cardiovasc Magn Reson 9:615-20
White, R James; Meoli, David F; Swarthout, Robert F et al. (2007) Plexiform-like lesions and increased tissue factor expression in a rat model of severe pulmonary arterial hypertension. Am J Physiol Lung Cell Mol Physiol 293:L583-90
Hathcock, James; Rusinova, Elena; Vaananen, Heikki et al. (2007) Lipid-bound factor Xa regulates tissue factor activity. Biochemistry 46:6134-40
Khorana, Alok A; Ahrendt, Steven A; Ryan, Charlotte K et al. (2007) Tissue factor expression, angiogenesis, and thrombosis in pancreatic cancer. Clin Cancer Res 13:2870-5
Pyo, Robert T; Sui, Jinliang; Dhume, Ashwini et al. (2006) CXCR4 modulates contractility in adult cardiac myocytes. J Mol Cell Cardiol 41:834-44
Bogdanov, V Y; Kirk, R I; Miller, C et al. (2006) Identification and characterization of murine alternatively spliced tissue factor. J Thromb Haemost 4:158-67

Showing the most recent 10 out of 91 publications